A Study of Selexipag in Healthy Male Participant

NCT04266756 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Selexipag matrix tablet
DRUG: Selexipag encapsulated pellets
DRUG: Selexipag Immediate-release (IR) tablet

Sponsor

Actelion